Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
| Year | Source | Title | |
|---|---|---|---|
| 2009 | HAYES, Inc. | deCODE ProstateCancer (deCODE diagnostics) | |
| 2009 | HAYES, Inc. | Late-onset familial alzheimer disease (AD2) | |
| 2009 | HAYES, Inc. | Maturity-Onset Diabetes of the Young (MODY) | |
| 2009 | HAYES, Inc. | MYH-Associated Polyposis (MAP) | |
| 2009 | HAYES, Inc. | PathFinderTG test for pancreatic cancer | |
| 2009 | HAYES, Inc. | Nanoparticle-based cancer therapies: Albumin-bound paclitaxel | |
| 2009 | HAYES, Inc. | Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II) | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical- and cost-effectiveness | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Fecal immunochemical tests for colorectal cancer screening of average risk individuals: a systematic review of accuracy and compliance | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Computed tomography: a review of the risk of cancer associated with radiation exposure | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Dabigatran or Rivaroxaban versus other anticoagulants for thromboprophylaxis after major orthopedic surgery: systematic review of comparative clinical-effectiveness and safety | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Dialectical Behavior Therapy in adolescents for suicide prevention: Systematic review of clinical-effectiveness | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Reassessment of health technologies: obsolescence and waste | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Development and testing of search filters to identify economic evaluations in MEDLINE and EMBASE | |
| 2009 | Canadian Agency for Drugs and Technologies in Health (CADTH) | Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation | |
| 2009 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Fast-track surgery and enhanced recovery after surgery (ERAS) programs | |
| 2009 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Endoscopic thoracic sympathectomy | |
| 2009 | Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) | Neoadjuvant radiochemotherapy for rectal cancer | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: Rapid assessment | |
| 2009 | Andalusian Health Technology Assessment Area (AETSA) | [The state of research into inequalities in the incidence, death, prevention and healthcare in cancer in Spain. A bibliometric study and literature review.] | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Magnetic Resonance Imaging: cost analysis | |
| 2009 | Finnish Office for Health Care Technology Assessment (Finohta) | Surgical treatment of morbid obesity | |
| 2009 | Finnish Office for Health Care Technology Assessment (Finohta) | [Evaluation of implementation of foetal screening] | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Tiotropium in the treatment of chronic obstructive pulmonary disease health technology assessment | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Positron Emission Tomography (PET) in Belgium: an update | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Pharmaceutical and non-pharmaceutical interventions for Alzheimer's Disease, a rapid assessment | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Policies for rare diseases and orphan drugs | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Endobronchial valves in the treatment of severe pulmonary emphysema: a rapid health technology assessment | |
| 2009 | Belgian Health Care Knowledge Centre (KCE) | Use of point-of-care devices in patients with oral anticoagulation : a Health Technology Assessment | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Microdeletion syndrome screening test(MLPA)] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [PRF1, UNC13D, STX11 gene, mutation[Sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SMN1/SMN2 gene [Gene dosage test]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [VHL exon deletion/duplication test[MLPA]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [PMP22 exon deletion/duplication test [MLPA]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [PMS2 gene mutation analysis(sequencing)] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [PROS1 exon deletion/duplication test[MLPA]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SERPINC1 exon deletion/duplication test [MLPA]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Heparin-Platelet Factor 4(PF4) antibody test] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SLC12A3 gene, mutation [sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SMN1 gene, mutation[sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Percutaneous tracheostomy dilator] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Intra-abdominal pressure monitoring with abviser] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Magnetic remote controlled catheter navigation technique] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [VKORCI genotyping[Real-time PCR-melting point analysis]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Corneal cross linking] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [NovaSure impedance] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Uterine tamponade of postpartal bleeding by ballooning catheter] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Radiofrequency(RF) ablation of high grade dysplastic nodule of the liver] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Radiofrequency(RF) ablation of hepatocellular adenoma] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Anti-saccharomyces cerevisiae antibody test] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SDHD gene, mutation[Sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SDHC gene, mutation[Sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SDHB gene, mutation[Sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Hyoid myotomy suspension] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Malaria antigen, rapid(target Ag:Aldolase,Histidine-rich protein-2)] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [F12 gene, mutation[sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [F7 gene, mutation[sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [IL2RG gene mutation analysis] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SNCA Gene Mutation Anaysis] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [GFAP gene, mutation[sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Continuous femoral nerve block] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Tonsillectomy with coblation] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Pressure wire] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [TruScreen - cervical cancer screening system] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [MUTYH gene mutation[Sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [ELA2 gene point mutation analysis] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [NTRK1 gene point mutation analysis] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [CoaguChek XS PT TEST] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [AMH] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Genotyping of MDM2 SNP309 polymorphism] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [ERCC1 RNA RT-PCR quantification] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [RRM1 RNA RT-PCR quantification] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Balloon tamponade for postpartum hemorrhage] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Endobronchial ultrasound/fine needle aspiration] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [SurePATH liquid-based cytology test for FNA(fine needle aspiration) specimens] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Antroduodenal manometry] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Cardio detect(h-FABP)] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [PDGFRA gene exon 12,18 mutation sequencing test] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Autologous noncultured epidermal cellular transplantation] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Anti-Heparin/Platelet Factor 4 antibody assey] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Intrastromal corneal ring surgery] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Allo skin graft] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [PHEX gene, Mutation[Sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [PRSS1 gene, Mutation[Sequencing]] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Peripheral nerve stimulation] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Extremely low temperature cool chamber] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [The vest airway clearance system] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Percutaneous cement injection plasty of metastatic bone tumor] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Autologous blood injection] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [ThinPrep liquid-based aspiration cytopathology test] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [JAK2 gene exon 12 mutation analysis] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [NPM1 gene sequencing analysis] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [High density EEG dipole source localization] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Epstein-Barr virus EA IgA] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Epstein-Barr virus VCA IgA] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Intramuscular transplantation of autologous bone marrow stem cell(therapeutic angiogenesis)] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [Transanal endoscopic microsurgery(TEM)] | |
| 2009 | Committee for New Health Technology Assessment (CNHTA) | [POCT(point of care test) prothrombin time] |